nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisolone—CYP2A6—Tamoxifen—pancreatic cancer	0.162	0.236	CbGbCtD
Prednisolone—CYP2A6—Fluorouracil—pancreatic cancer	0.119	0.174	CbGbCtD
Prednisolone—ABCB1—Tamoxifen—pancreatic cancer	0.0539	0.0786	CbGbCtD
Prednisolone—ABCB1—Gemcitabine—pancreatic cancer	0.0464	0.0677	CbGbCtD
Prednisolone—ABCB1—Erlotinib—pancreatic cancer	0.0458	0.0668	CbGbCtD
Prednisolone—ABCB1—Irinotecan—pancreatic cancer	0.0414	0.0604	CbGbCtD
Prednisolone—CYP3A4—Tamoxifen—pancreatic cancer	0.0323	0.0471	CbGbCtD
Prednisolone—ABCB1—Docetaxel—pancreatic cancer	0.0303	0.0442	CbGbCtD
Prednisolone—ABCB1—Sunitinib—pancreatic cancer	0.0302	0.044	CbGbCtD
Prednisolone—CYP3A4—Erlotinib—pancreatic cancer	0.0275	0.0401	CbGbCtD
Prednisolone—CYP3A4—Irinotecan—pancreatic cancer	0.0248	0.0362	CbGbCtD
Prednisolone—ABCB1—Doxorubicin—pancreatic cancer	0.0226	0.033	CbGbCtD
Prednisolone—CYP3A4—Docetaxel—pancreatic cancer	0.0182	0.0265	CbGbCtD
Prednisolone—CYP3A4—Sunitinib—pancreatic cancer	0.0181	0.0264	CbGbCtD
Prednisolone—CYP3A4—Doxorubicin—pancreatic cancer	0.0136	0.0198	CbGbCtD
Prednisolone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFE2L2—pancreatic cancer	0.000906	0.032	CbGpPWpGaD
Prednisolone—NR3C1—Nuclear Receptors—NR5A2—pancreatic cancer	0.000823	0.029	CbGpPWpGaD
Prednisolone—Visual disturbance—Docetaxel—pancreatic cancer	0.000664	0.00232	CcSEcCtD
Prednisolone—Acute coronary syndrome—Fluorouracil—pancreatic cancer	0.000662	0.00232	CcSEcCtD
Prednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—PDX1—pancreatic cancer	0.000662	0.0233	CbGpPWpGaD
Prednisolone—Myocardial infarction—Fluorouracil—pancreatic cancer	0.000658	0.0023	CcSEcCtD
Prednisolone—Neuropathy peripheral—Fluorouracil—pancreatic cancer	0.000658	0.0023	CcSEcCtD
Prednisolone—Dermatitis bullous—Docetaxel—pancreatic cancer	0.000658	0.0023	CcSEcCtD
Prednisolone—Petechiae—Doxorubicin—pancreatic cancer	0.000657	0.0023	CcSEcCtD
Prednisolone—Discomfort—Tamoxifen—pancreatic cancer	0.000653	0.00229	CcSEcCtD
Prednisolone—Conjunctivitis—Fluorouracil—pancreatic cancer	0.000653	0.00228	CcSEcCtD
Prednisolone—NR3C1—Nuclear Receptor transcription pathway—NR5A2—pancreatic cancer	0.00065	0.0229	CbGpPWpGaD
Prednisolone—Viral infection—Epirubicin—pancreatic cancer	0.000647	0.00226	CcSEcCtD
Prednisolone—Arthropathy—Epirubicin—pancreatic cancer	0.000643	0.00225	CcSEcCtD
Prednisolone—Bradycardia—Irinotecan—pancreatic cancer	0.000641	0.00224	CcSEcCtD
Prednisolone—Herpes simplex—Epirubicin—pancreatic cancer	0.000634	0.00222	CcSEcCtD
Prednisolone—Oedema—Tamoxifen—pancreatic cancer	0.000634	0.00222	CcSEcCtD
Prednisolone—Haemoglobin—Irinotecan—pancreatic cancer	0.000633	0.00221	CcSEcCtD
Prednisolone—CYP2A6—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.00063	0.0222	CbGpPWpGaD
Prednisolone—Haemorrhage—Irinotecan—pancreatic cancer	0.000629	0.0022	CcSEcCtD
Prednisolone—Oedema—Erlotinib—pancreatic cancer	0.000627	0.00219	CcSEcCtD
Prednisolone—Shock—Erlotinib—pancreatic cancer	0.000617	0.00216	CcSEcCtD
Prednisolone—Haemoglobin—Gemcitabine—pancreatic cancer	0.000616	0.00216	CcSEcCtD
Prednisolone—NR3C2—ACE Inhibitor Pathway—TGFB1—pancreatic cancer	0.000614	0.0216	CbGpPWpGaD
Prednisolone—Haemorrhage—Gemcitabine—pancreatic cancer	0.000613	0.00214	CcSEcCtD
Prednisolone—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.000613	0.00214	CcSEcCtD
Prednisolone—Angioedema—Sunitinib—pancreatic cancer	0.000608	0.00213	CcSEcCtD
Prednisolone—Visual impairment—Irinotecan—pancreatic cancer	0.000607	0.00212	CcSEcCtD
Prednisolone—Haemoglobin—Fluorouracil—pancreatic cancer	0.000606	0.00212	CcSEcCtD
Prednisolone—Haemorrhage—Fluorouracil—pancreatic cancer	0.000603	0.00211	CcSEcCtD
Prednisolone—Viral infection—Doxorubicin—pancreatic cancer	0.000599	0.00209	CcSEcCtD
Prednisolone—Arthropathy—Doxorubicin—pancreatic cancer	0.000595	0.00208	CcSEcCtD
Prednisolone—Herpes simplex—Doxorubicin—pancreatic cancer	0.000587	0.00205	CcSEcCtD
Prednisolone—Hiccups—Epirubicin—pancreatic cancer	0.000584	0.00204	CcSEcCtD
Prednisolone—Dry skin—Docetaxel—pancreatic cancer	0.000577	0.00202	CcSEcCtD
Prednisolone—Convulsion—Sunitinib—pancreatic cancer	0.000576	0.00202	CcSEcCtD
Prednisolone—Hypertension—Sunitinib—pancreatic cancer	0.000574	0.00201	CcSEcCtD
Prednisolone—Insomnia—Tamoxifen—pancreatic cancer	0.000573	0.00201	CcSEcCtD
Prednisolone—Paraesthesia—Tamoxifen—pancreatic cancer	0.000569	0.00199	CcSEcCtD
Prednisolone—Insomnia—Erlotinib—pancreatic cancer	0.000567	0.00198	CcSEcCtD
Prednisolone—Arrhythmia—Irinotecan—pancreatic cancer	0.000562	0.00197	CcSEcCtD
Prednisolone—Fluid retention—Epirubicin—pancreatic cancer	0.000555	0.00194	CcSEcCtD
Prednisolone—CYP2A6—NRF2 pathway—FGF13—pancreatic cancer	0.000551	0.0194	CbGpPWpGaD
Prednisolone—Neuropathy—Epirubicin—pancreatic cancer	0.000549	0.00192	CcSEcCtD
Prednisolone—Arrhythmia—Gemcitabine—pancreatic cancer	0.000548	0.00192	CcSEcCtD
Prednisolone—Oedema—Sunitinib—pancreatic cancer	0.000543	0.0019	CcSEcCtD
Prednisolone—Pain—Tamoxifen—pancreatic cancer	0.000542	0.0019	CcSEcCtD
Prednisolone—Hiccups—Doxorubicin—pancreatic cancer	0.000541	0.00189	CcSEcCtD
Prednisolone—Arrhythmia—Fluorouracil—pancreatic cancer	0.000539	0.00188	CcSEcCtD
Prednisolone—Pain—Erlotinib—pancreatic cancer	0.000536	0.00188	CcSEcCtD
Prednisolone—Shock—Sunitinib—pancreatic cancer	0.000534	0.00187	CcSEcCtD
Prednisolone—Erythema—Gemcitabine—pancreatic cancer	0.000534	0.00187	CcSEcCtD
Prednisolone—Ecchymosis—Epirubicin—pancreatic cancer	0.000528	0.00185	CcSEcCtD
Prednisolone—Erythema—Fluorouracil—pancreatic cancer	0.000525	0.00184	CcSEcCtD
Prednisolone—Pulmonary oedema—Epirubicin—pancreatic cancer	0.00052	0.00182	CcSEcCtD
Prednisolone—Fluid retention—Doxorubicin—pancreatic cancer	0.000513	0.0018	CcSEcCtD
Prednisolone—Ill-defined disorder—Irinotecan—pancreatic cancer	0.000508	0.00178	CcSEcCtD
Prednisolone—Neuropathy—Doxorubicin—pancreatic cancer	0.000508	0.00178	CcSEcCtD
Prednisolone—Urticaria—Tamoxifen—pancreatic cancer	0.000504	0.00176	CcSEcCtD
Prednisolone—CYP2A6—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.0005	0.0176	CbGpPWpGaD
Prednisolone—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.000495	0.00173	CcSEcCtD
Prednisolone—Weight increased—Docetaxel—pancreatic cancer	0.000495	0.00173	CcSEcCtD
Prednisolone—Vision blurred—Fluorouracil—pancreatic cancer	0.000495	0.00173	CcSEcCtD
Prednisolone—Malaise—Irinotecan—pancreatic cancer	0.000494	0.00173	CcSEcCtD
Prednisolone—Vertigo—Irinotecan—pancreatic cancer	0.000492	0.00172	CcSEcCtD
Prednisolone—Syncope—Irinotecan—pancreatic cancer	0.000491	0.00172	CcSEcCtD
Prednisolone—Insomnia—Sunitinib—pancreatic cancer	0.000491	0.00172	CcSEcCtD
Prednisolone—Thrombophlebitis—Epirubicin—pancreatic cancer	0.00049	0.00171	CcSEcCtD
Prednisolone—NR3C1—Endoderm Differentiation—DAB2—pancreatic cancer	0.00049	0.0173	CbGpPWpGaD
Prednisolone—Ecchymosis—Doxorubicin—pancreatic cancer	0.000489	0.00171	CcSEcCtD
Prednisolone—Diabetes mellitus—Epirubicin—pancreatic cancer	0.000488	0.00171	CcSEcCtD
Prednisolone—Paraesthesia—Sunitinib—pancreatic cancer	0.000487	0.00171	CcSEcCtD
Prednisolone—Loss of consciousness—Irinotecan—pancreatic cancer	0.000482	0.00168	CcSEcCtD
Prednisolone—Malaise—Gemcitabine—pancreatic cancer	0.000481	0.00168	CcSEcCtD
Prednisolone—Pulmonary oedema—Doxorubicin—pancreatic cancer	0.000481	0.00168	CcSEcCtD
Prednisolone—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.000478	0.00167	CcSEcCtD
Prednisolone—Neuropathy peripheral—Docetaxel—pancreatic cancer	0.000475	0.00166	CcSEcCtD
Prednisolone—Myocardial infarction—Docetaxel—pancreatic cancer	0.000475	0.00166	CcSEcCtD
Prednisolone—Hypertension—Irinotecan—pancreatic cancer	0.000473	0.00165	CcSEcCtD
Prednisolone—Conjunctivitis—Docetaxel—pancreatic cancer	0.000471	0.00165	CcSEcCtD
Prednisolone—Cardiac failure congestive—Epirubicin—pancreatic cancer	0.000468	0.00164	CcSEcCtD
Prednisolone—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000467	0.00163	CcSEcCtD
Prednisolone—Pain—Sunitinib—pancreatic cancer	0.000464	0.00162	CcSEcCtD
Prednisolone—Discomfort—Irinotecan—pancreatic cancer	0.000461	0.00161	CcSEcCtD
Prednisolone—Hypertension—Gemcitabine—pancreatic cancer	0.000461	0.00161	CcSEcCtD
Prednisolone—Convulsion—Fluorouracil—pancreatic cancer	0.000455	0.00159	CcSEcCtD
Prednisolone—Thrombophlebitis—Doxorubicin—pancreatic cancer	0.000453	0.00159	CcSEcCtD
Prednisolone—Increased appetite—Epirubicin—pancreatic cancer	0.000452	0.00158	CcSEcCtD
Prednisolone—Diabetes mellitus—Doxorubicin—pancreatic cancer	0.000451	0.00158	CcSEcCtD
Prednisolone—Discomfort—Gemcitabine—pancreatic cancer	0.000449	0.00157	CcSEcCtD
Prednisolone—NR3C2—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.000448	0.0158	CbGpPWpGaD
Prednisolone—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000447	0.00156	CcSEcCtD
Prednisolone—Oedema—Irinotecan—pancreatic cancer	0.000447	0.00156	CcSEcCtD
Prednisolone—Dermatitis bullous—Epirubicin—pancreatic cancer	0.000444	0.00155	CcSEcCtD
Prednisolone—Discomfort—Fluorouracil—pancreatic cancer	0.000441	0.00154	CcSEcCtD
Prednisolone—Shock—Irinotecan—pancreatic cancer	0.00044	0.00154	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.000438	0.00153	CcSEcCtD
Prednisolone—Haemoglobin—Docetaxel—pancreatic cancer	0.000437	0.00153	CcSEcCtD
Prednisolone—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000436	0.00152	CcSEcCtD
Prednisolone—Oedema—Gemcitabine—pancreatic cancer	0.000436	0.00152	CcSEcCtD
Prednisolone—Haemorrhage—Docetaxel—pancreatic cancer	0.000435	0.00152	CcSEcCtD
Prednisolone—Cardiac failure congestive—Doxorubicin—pancreatic cancer	0.000433	0.00151	CcSEcCtD
Prednisolone—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000432	0.00151	CcSEcCtD
Prednisolone—Oedema—Fluorouracil—pancreatic cancer	0.000428	0.0015	CcSEcCtD
Prednisolone—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000428	0.0015	CcSEcCtD
Prednisolone—Osteoarthritis—Epirubicin—pancreatic cancer	0.000424	0.00148	CcSEcCtD
Prednisolone—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000421	0.00147	CcSEcCtD
Prednisolone—Visual impairment—Docetaxel—pancreatic cancer	0.000419	0.00147	CcSEcCtD
Prednisolone—Dizziness—Tamoxifen—pancreatic cancer	0.000419	0.00147	CcSEcCtD
Prednisolone—Tachycardia—Fluorouracil—pancreatic cancer	0.000418	0.00146	CcSEcCtD
Prednisolone—Increased appetite—Doxorubicin—pancreatic cancer	0.000418	0.00146	CcSEcCtD
Prednisolone—Affect lability—Epirubicin—pancreatic cancer	0.000418	0.00146	CcSEcCtD
Prednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—SLC2A2—pancreatic cancer	0.000417	0.0147	CbGpPWpGaD
Prednisolone—Dizziness—Erlotinib—pancreatic cancer	0.000415	0.00145	CcSEcCtD
Prednisolone—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.000411	0.00144	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.000406	0.00142	CcSEcCtD
Prednisolone—Insomnia—Irinotecan—pancreatic cancer	0.000404	0.00141	CcSEcCtD
Prednisolone—Cardiac arrest—Epirubicin—pancreatic cancer	0.000403	0.00141	CcSEcCtD
Prednisolone—Mood swings—Epirubicin—pancreatic cancer	0.000402	0.00141	CcSEcCtD
Prednisolone—Paraesthesia—Irinotecan—pancreatic cancer	0.000402	0.0014	CcSEcCtD
Prednisolone—Hypersensitivity—Sunitinib—pancreatic cancer	0.0004	0.0014	CcSEcCtD
Prednisolone—Rash—Tamoxifen—pancreatic cancer	0.0004	0.0014	CcSEcCtD
Prednisolone—Dermatitis—Tamoxifen—pancreatic cancer	0.000399	0.0014	CcSEcCtD
Prednisolone—Headache—Tamoxifen—pancreatic cancer	0.000397	0.00139	CcSEcCtD
Prednisolone—Rash—Erlotinib—pancreatic cancer	0.000395	0.00138	CcSEcCtD
Prednisolone—Dermatitis—Erlotinib—pancreatic cancer	0.000395	0.00138	CcSEcCtD
Prednisolone—Insomnia—Gemcitabine—pancreatic cancer	0.000394	0.00138	CcSEcCtD
Prednisolone—Headache—Erlotinib—pancreatic cancer	0.000393	0.00137	CcSEcCtD
Prednisolone—Osteoarthritis—Doxorubicin—pancreatic cancer	0.000393	0.00137	CcSEcCtD
Prednisolone—Paraesthesia—Gemcitabine—pancreatic cancer	0.000391	0.00137	CcSEcCtD
Prednisolone—Dry skin—Epirubicin—pancreatic cancer	0.000389	0.00136	CcSEcCtD
Prednisolone—Arrhythmia—Docetaxel—pancreatic cancer	0.000389	0.00136	CcSEcCtD
Prednisolone—Insomnia—Fluorouracil—pancreatic cancer	0.000387	0.00136	CcSEcCtD
Prednisolone—Affect lability—Doxorubicin—pancreatic cancer	0.000386	0.00135	CcSEcCtD
Prednisolone—NR3C2—Preimplantation Embryo—CDH1—pancreatic cancer	0.000385	0.0136	CbGpPWpGaD
Prednisolone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—pancreatic cancer	0.000385	0.0136	CbGpPWpGaD
Prednisolone—Paraesthesia—Fluorouracil—pancreatic cancer	0.000385	0.00135	CcSEcCtD
Prednisolone—Pain—Irinotecan—pancreatic cancer	0.000382	0.00134	CcSEcCtD
Prednisolone—Erythema—Docetaxel—pancreatic cancer	0.000379	0.00133	CcSEcCtD
Prednisolone—Nausea—Tamoxifen—pancreatic cancer	0.000376	0.00132	CcSEcCtD
Prednisolone—Muscular weakness—Epirubicin—pancreatic cancer	0.000374	0.00131	CcSEcCtD
Prednisolone—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000373	0.00131	CcSEcCtD
Prednisolone—Pain—Gemcitabine—pancreatic cancer	0.000373	0.0013	CcSEcCtD
Prednisolone—Nausea—Erlotinib—pancreatic cancer	0.000372	0.0013	CcSEcCtD
Prednisolone—Mood swings—Doxorubicin—pancreatic cancer	0.000372	0.0013	CcSEcCtD
Prednisolone—Abdominal distension—Epirubicin—pancreatic cancer	0.000369	0.00129	CcSEcCtD
Prednisolone—Feeling abnormal—Irinotecan—pancreatic cancer	0.000369	0.00129	CcSEcCtD
Prednisolone—Pain—Fluorouracil—pancreatic cancer	0.000366	0.00128	CcSEcCtD
Prednisolone—Dry skin—Doxorubicin—pancreatic cancer	0.00036	0.00126	CcSEcCtD
Prednisolone—Pancreatitis—Epirubicin—pancreatic cancer	0.000359	0.00126	CcSEcCtD
Prednisolone—Dizziness—Sunitinib—pancreatic cancer	0.000359	0.00126	CcSEcCtD
Prednisolone—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000359	0.00126	CcSEcCtD
Prednisolone—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000353	0.00123	CcSEcCtD
Prednisolone—Muscular weakness—Doxorubicin—pancreatic cancer	0.000346	0.00121	CcSEcCtD
Prednisolone—Rash—Sunitinib—pancreatic cancer	0.000342	0.0012	CcSEcCtD
Prednisolone—Dermatitis—Sunitinib—pancreatic cancer	0.000342	0.0012	CcSEcCtD
Prednisolone—Abdominal distension—Doxorubicin—pancreatic cancer	0.000342	0.00119	CcSEcCtD
Prednisolone—Urticaria—Fluorouracil—pancreatic cancer	0.00034	0.00119	CcSEcCtD
Prednisolone—Headache—Sunitinib—pancreatic cancer	0.00034	0.00119	CcSEcCtD
Prednisolone—Syncope—Docetaxel—pancreatic cancer	0.00034	0.00119	CcSEcCtD
Prednisolone—SLCO1A2—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.000335	0.0118	CbGpPWpGaD
Prednisolone—Weight increased—Epirubicin—pancreatic cancer	0.000334	0.00117	CcSEcCtD
Prednisolone—Loss of consciousness—Docetaxel—pancreatic cancer	0.000333	0.00116	CcSEcCtD
Prednisolone—Pancreatitis—Doxorubicin—pancreatic cancer	0.000333	0.00116	CcSEcCtD
Prednisolone—Hypersensitivity—Irinotecan—pancreatic cancer	0.000329	0.00115	CcSEcCtD
Prednisolone—Convulsion—Docetaxel—pancreatic cancer	0.000328	0.00115	CcSEcCtD
Prednisolone—Hypertension—Docetaxel—pancreatic cancer	0.000327	0.00114	CcSEcCtD
Prednisolone—Nausea—Sunitinib—pancreatic cancer	0.000322	0.00113	CcSEcCtD
Prednisolone—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.00032	0.00112	CcSEcCtD
Prednisolone—NR3C2—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.000319	0.0113	CbGpPWpGaD
Prednisolone—Conjunctivitis—Epirubicin—pancreatic cancer	0.000318	0.00111	CcSEcCtD
Prednisolone—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000316	0.0011	CcSEcCtD
Prednisolone—Oedema—Docetaxel—pancreatic cancer	0.000309	0.00108	CcSEcCtD
Prednisolone—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000309	0.00108	CcSEcCtD
Prednisolone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—pancreatic cancer	0.000309	0.0109	CbGpPWpGaD
Prednisolone—Weight increased—Doxorubicin—pancreatic cancer	0.000309	0.00108	CcSEcCtD
Prednisolone—Shock—Docetaxel—pancreatic cancer	0.000304	0.00106	CcSEcCtD
Prednisolone—Tachycardia—Docetaxel—pancreatic cancer	0.000302	0.00106	CcSEcCtD
Prednisolone—Bradycardia—Epirubicin—pancreatic cancer	0.000299	0.00105	CcSEcCtD
Prednisolone—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000297	0.00104	CcSEcCtD
Prednisolone—Dizziness—Irinotecan—pancreatic cancer	0.000296	0.00103	CcSEcCtD
Prednisolone—Haemoglobin—Epirubicin—pancreatic cancer	0.000295	0.00103	CcSEcCtD
Prednisolone—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000294	0.00103	CcSEcCtD
Prednisolone—Haemorrhage—Epirubicin—pancreatic cancer	0.000293	0.00103	CcSEcCtD
Prednisolone—CYP2A6—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.000285	0.01	CbGpPWpGaD
Prednisolone—Dizziness—Fluorouracil—pancreatic cancer	0.000283	0.000991	CcSEcCtD
Prednisolone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—pancreatic cancer	0.000283	0.00999	CbGpPWpGaD
Prednisolone—Visual impairment—Epirubicin—pancreatic cancer	0.000283	0.000989	CcSEcCtD
Prednisolone—Rash—Irinotecan—pancreatic cancer	0.000282	0.000986	CcSEcCtD
Prednisolone—Dermatitis—Irinotecan—pancreatic cancer	0.000282	0.000985	CcSEcCtD
Prednisolone—Headache—Irinotecan—pancreatic cancer	0.00028	0.00098	CcSEcCtD
Prednisolone—Insomnia—Docetaxel—pancreatic cancer	0.00028	0.000978	CcSEcCtD
Prednisolone—Paraesthesia—Docetaxel—pancreatic cancer	0.000278	0.000971	CcSEcCtD
Prednisolone—Bradycardia—Doxorubicin—pancreatic cancer	0.000276	0.000967	CcSEcCtD
Prednisolone—Rash—Gemcitabine—pancreatic cancer	0.000275	0.000961	CcSEcCtD
Prednisolone—Dermatitis—Gemcitabine—pancreatic cancer	0.000274	0.00096	CcSEcCtD
Prednisolone—Haemoglobin—Doxorubicin—pancreatic cancer	0.000273	0.000955	CcSEcCtD
Prednisolone—Headache—Gemcitabine—pancreatic cancer	0.000273	0.000955	CcSEcCtD
Prednisolone—Haemorrhage—Doxorubicin—pancreatic cancer	0.000272	0.00095	CcSEcCtD
Prednisolone—Rash—Fluorouracil—pancreatic cancer	0.00027	0.000945	CcSEcCtD
Prednisolone—Dermatitis—Fluorouracil—pancreatic cancer	0.00027	0.000944	CcSEcCtD
Prednisolone—Headache—Fluorouracil—pancreatic cancer	0.000268	0.000939	CcSEcCtD
Prednisolone—NR3C1—Endoderm Differentiation—PTHLH—pancreatic cancer	0.000268	0.00946	CbGpPWpGaD
Prednisolone—Nausea—Irinotecan—pancreatic cancer	0.000266	0.000929	CcSEcCtD
Prednisolone—Pain—Docetaxel—pancreatic cancer	0.000264	0.000925	CcSEcCtD
Prednisolone—Arrhythmia—Epirubicin—pancreatic cancer	0.000262	0.000917	CcSEcCtD
Prednisolone—Visual impairment—Doxorubicin—pancreatic cancer	0.000262	0.000915	CcSEcCtD
Prednisolone—Nausea—Gemcitabine—pancreatic cancer	0.000259	0.000905	CcSEcCtD
Prednisolone—Erythema—Epirubicin—pancreatic cancer	0.000255	0.000894	CcSEcCtD
Prednisolone—Feeling abnormal—Docetaxel—pancreatic cancer	0.000255	0.000891	CcSEcCtD
Prednisolone—Nausea—Fluorouracil—pancreatic cancer	0.000254	0.00089	CcSEcCtD
Prednisolone—NR3C1—Endoderm Differentiation—EZH2—pancreatic cancer	0.000244	0.00862	CbGpPWpGaD
Prednisolone—Arrhythmia—Doxorubicin—pancreatic cancer	0.000243	0.000849	CcSEcCtD
Prednisolone—Vision blurred—Epirubicin—pancreatic cancer	0.000241	0.000842	CcSEcCtD
Prednisolone—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000237	0.000829	CcSEcCtD
Prednisolone—Erythema—Doxorubicin—pancreatic cancer	0.000236	0.000827	CcSEcCtD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—SSTR1—pancreatic cancer	0.00023	0.00813	CbGpPWpGaD
Prednisolone—Malaise—Epirubicin—pancreatic cancer	0.00023	0.000806	CcSEcCtD
Prednisolone—Vertigo—Epirubicin—pancreatic cancer	0.00023	0.000803	CcSEcCtD
Prednisolone—Syncope—Epirubicin—pancreatic cancer	0.000229	0.000801	CcSEcCtD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—NDRG1—pancreatic cancer	0.000229	0.00808	CbGpPWpGaD
Prednisolone—Hypersensitivity—Docetaxel—pancreatic cancer	0.000228	0.000797	CcSEcCtD
Prednisolone—Loss of consciousness—Epirubicin—pancreatic cancer	0.000225	0.000786	CcSEcCtD
Prednisolone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—pancreatic cancer	0.000223	0.00787	CbGpPWpGaD
Prednisolone—Vision blurred—Doxorubicin—pancreatic cancer	0.000223	0.000779	CcSEcCtD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—SSTR2—pancreatic cancer	0.000222	0.00782	CbGpPWpGaD
Prednisolone—Convulsion—Epirubicin—pancreatic cancer	0.000221	0.000774	CcSEcCtD
Prednisolone—Hypertension—Epirubicin—pancreatic cancer	0.000221	0.000772	CcSEcCtD
Prednisolone—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000219	0.000767	CcSEcCtD
Prednisolone—Discomfort—Epirubicin—pancreatic cancer	0.000215	0.000752	CcSEcCtD
Prednisolone—Malaise—Doxorubicin—pancreatic cancer	0.000213	0.000746	CcSEcCtD
Prednisolone—Vertigo—Doxorubicin—pancreatic cancer	0.000212	0.000743	CcSEcCtD
Prednisolone—Syncope—Doxorubicin—pancreatic cancer	0.000212	0.000742	CcSEcCtD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000209	0.00736	CbGpPWpGaD
Prednisolone—Oedema—Epirubicin—pancreatic cancer	0.000209	0.000729	CcSEcCtD
Prednisolone—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000209	0.000729	CcSEcCtD
Prednisolone—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000208	0.000727	CcSEcCtD
Prednisolone—Shock—Epirubicin—pancreatic cancer	0.000205	0.000718	CcSEcCtD
Prednisolone—Convulsion—Doxorubicin—pancreatic cancer	0.000205	0.000716	CcSEcCtD
Prednisolone—Dizziness—Docetaxel—pancreatic cancer	0.000204	0.000715	CcSEcCtD
Prednisolone—Hypertension—Doxorubicin—pancreatic cancer	0.000204	0.000714	CcSEcCtD
Prednisolone—Tachycardia—Epirubicin—pancreatic cancer	0.000203	0.000712	CcSEcCtD
Prednisolone—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000202	0.000705	CcSEcCtD
Prednisolone—NR3C1—Nuclear Receptors—PPARG—pancreatic cancer	0.0002	0.00704	CbGpPWpGaD
Prednisolone—Discomfort—Doxorubicin—pancreatic cancer	0.000199	0.000696	CcSEcCtD
Prednisolone—Rash—Docetaxel—pancreatic cancer	0.000195	0.000682	CcSEcCtD
Prednisolone—Dermatitis—Docetaxel—pancreatic cancer	0.000195	0.000681	CcSEcCtD
Prednisolone—Headache—Docetaxel—pancreatic cancer	0.000194	0.000677	CcSEcCtD
Prednisolone—Oedema—Doxorubicin—pancreatic cancer	0.000193	0.000675	CcSEcCtD
Prednisolone—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000193	0.000675	CcSEcCtD
Prednisolone—NR3C1—Adipogenesis—AHR—pancreatic cancer	0.000193	0.0068	CbGpPWpGaD
Prednisolone—Shock—Doxorubicin—pancreatic cancer	0.00019	0.000664	CcSEcCtD
Prednisolone—Insomnia—Epirubicin—pancreatic cancer	0.000189	0.00066	CcSEcCtD
Prednisolone—Tachycardia—Doxorubicin—pancreatic cancer	0.000188	0.000659	CcSEcCtD
Prednisolone—Paraesthesia—Epirubicin—pancreatic cancer	0.000187	0.000655	CcSEcCtD
Prednisolone—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000187	0.000652	CcSEcCtD
Prednisolone—Nausea—Docetaxel—pancreatic cancer	0.000184	0.000642	CcSEcCtD
Prednisolone—NR3C2—Gene Expression—CHD3—pancreatic cancer	0.000183	0.00646	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—MEN1—pancreatic cancer	0.000183	0.00646	CbGpPWpGaD
Prednisolone—NR3C1—Endoderm Differentiation—SMAD4—pancreatic cancer	0.00018	0.00635	CbGpPWpGaD
Prednisolone—Pain—Epirubicin—pancreatic cancer	0.000178	0.000624	CcSEcCtD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	0.000175	0.00616	CbGpPWpGaD
Prednisolone—NR3C1—Circadian Clock—HIF1A—pancreatic cancer	0.000175	0.00616	CbGpPWpGaD
Prednisolone—Insomnia—Doxorubicin—pancreatic cancer	0.000174	0.00061	CcSEcCtD
Prednisolone—NR3C2—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000174	0.00613	CbGpPWpGaD
Prednisolone—Paraesthesia—Doxorubicin—pancreatic cancer	0.000173	0.000606	CcSEcCtD
Prednisolone—Feeling abnormal—Epirubicin—pancreatic cancer	0.000172	0.000601	CcSEcCtD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00017	0.006	CbGpPWpGaD
Prednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—pancreatic cancer	0.000168	0.00591	CbGpPWpGaD
Prednisolone—Urticaria—Epirubicin—pancreatic cancer	0.000166	0.000579	CcSEcCtD
Prednisolone—Pain—Doxorubicin—pancreatic cancer	0.000165	0.000577	CcSEcCtD
Prednisolone—NR3C1—Transcription factor regulation in adipogenesis—TNF—pancreatic cancer	0.000164	0.00579	CbGpPWpGaD
Prednisolone—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000159	0.000556	CcSEcCtD
Prednisolone—NR3C1—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.000158	0.00556	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD4—pancreatic cancer	0.000157	0.00552	CbGpPWpGaD
Prednisolone—CYP2A6—NRF2 pathway—NFE2L2—pancreatic cancer	0.000155	0.00545	CbGpPWpGaD
Prednisolone—Hypersensitivity—Epirubicin—pancreatic cancer	0.000154	0.000537	CcSEcCtD
Prednisolone—NR3C2—Gene Expression—NR5A2—pancreatic cancer	0.000154	0.00542	CbGpPWpGaD
Prednisolone—Urticaria—Doxorubicin—pancreatic cancer	0.000153	0.000536	CcSEcCtD
Prednisolone—NR3C2—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.000148	0.00521	CbGpPWpGaD
Prednisolone—CYP2A6—NRF2 pathway—TGFA—pancreatic cancer	0.000147	0.0052	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.000145	0.00511	CbGpPWpGaD
Prednisolone—CYP2A6—NRF2 pathway—SLC2A2—pancreatic cancer	0.000144	0.00509	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—HIF1A—pancreatic cancer	0.000144	0.00508	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—GADD45A—pancreatic cancer	0.000143	0.00504	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—PLAU—pancreatic cancer	0.000143	0.00503	CbGpPWpGaD
Prednisolone—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000142	0.000497	CcSEcCtD
Prednisolone—Dizziness—Epirubicin—pancreatic cancer	0.000138	0.000482	CcSEcCtD
Prednisolone—NR3C1—Endoderm Differentiation—NOTCH1—pancreatic cancer	0.000133	0.00468	CbGpPWpGaD
Prednisolone—Rash—Epirubicin—pancreatic cancer	0.000131	0.00046	CcSEcCtD
Prednisolone—Dermatitis—Epirubicin—pancreatic cancer	0.000131	0.000459	CcSEcCtD
Prednisolone—Headache—Epirubicin—pancreatic cancer	0.000131	0.000457	CcSEcCtD
Prednisolone—Dizziness—Doxorubicin—pancreatic cancer	0.000128	0.000446	CcSEcCtD
Prednisolone—SLCO1A2—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000126	0.00446	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—SST—pancreatic cancer	0.000126	0.00445	CbGpPWpGaD
Prednisolone—Nausea—Epirubicin—pancreatic cancer	0.000124	0.000433	CcSEcCtD
Prednisolone—Rash—Doxorubicin—pancreatic cancer	0.000122	0.000426	CcSEcCtD
Prednisolone—Dermatitis—Doxorubicin—pancreatic cancer	0.000122	0.000425	CcSEcCtD
Prednisolone—Headache—Doxorubicin—pancreatic cancer	0.000121	0.000423	CcSEcCtD
Prednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000117	0.00413	CbGpPWpGaD
Prednisolone—Nausea—Doxorubicin—pancreatic cancer	0.000115	0.000401	CcSEcCtD
Prednisolone—NR3C1—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.000112	0.00396	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000111	0.00392	CbGpPWpGaD
Prednisolone—CYP2A6—NRF2 pathway—HSPA1A—pancreatic cancer	0.000111	0.00391	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.000105	0.00371	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—CDKN2A—pancreatic cancer	0.000103	0.00363	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—AGTR1—pancreatic cancer	9.94e-05	0.00351	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—SMAD4—pancreatic cancer	9.91e-05	0.00349	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of Androgen receptor activity—SRC—pancreatic cancer	9.73e-05	0.00343	CbGpPWpGaD
Prednisolone—CYP2A6—Fluoropyrimidine Activity—TP53—pancreatic cancer	9.44e-05	0.00333	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—CXCL8—pancreatic cancer	9.34e-05	0.00329	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—HES1—pancreatic cancer	9.05e-05	0.00319	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	8.93e-05	0.00315	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—MEN1—pancreatic cancer	8.82e-05	0.00311	CbGpPWpGaD
Prednisolone—NR3C1—Endoderm Differentiation—CTNNB1—pancreatic cancer	8.82e-05	0.00311	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—HIF1A—pancreatic cancer	8.77e-05	0.00309	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—CCND1—pancreatic cancer	8.7e-05	0.00307	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—CTNNB1—pancreatic cancer	8.62e-05	0.00304	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—TERT—pancreatic cancer	8.48e-05	0.00299	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—MMP9—pancreatic cancer	8.45e-05	0.00298	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—PTEN—pancreatic cancer	8.4e-05	0.00296	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—NOTCH4—pancreatic cancer	8.36e-05	0.00295	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—pancreatic cancer	8.23e-05	0.0029	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—NOTCH1—pancreatic cancer	8.2e-05	0.00289	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—HIF1A—pancreatic cancer	8.11e-05	0.00286	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—HSPA1B—pancreatic cancer	7.98e-05	0.00281	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—PPARG—pancreatic cancer	7.74e-05	0.00273	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	7.58e-05	0.00267	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—PPARG—pancreatic cancer	7.46e-05	0.00263	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	7.42e-05	0.00262	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	7.28e-05	0.00257	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—EZH2—pancreatic cancer	7.26e-05	0.00256	CbGpPWpGaD
Prednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	7.22e-05	0.00255	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—RB1—pancreatic cancer	7.14e-05	0.00252	CbGpPWpGaD
Prednisolone—NR3C1—Endoderm Differentiation—TGFB1—pancreatic cancer	7.13e-05	0.00251	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—NOTCH3—pancreatic cancer	7.11e-05	0.00251	CbGpPWpGaD
Prednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	7.02e-05	0.00248	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—MYC—pancreatic cancer	6.98e-05	0.00246	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—TGFB1—pancreatic cancer	6.96e-05	0.00246	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—HSPA1A—pancreatic cancer	6.73e-05	0.00237	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	6.65e-05	0.00235	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	6.57e-05	0.00232	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—CHD3—pancreatic cancer	6.45e-05	0.00228	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—MEN1—pancreatic cancer	6.45e-05	0.00227	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	6.42e-05	0.00227	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	6.21e-05	0.00219	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—NOTCH4—pancreatic cancer	6.11e-05	0.00216	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	5.74e-05	0.00203	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—TP53—pancreatic cancer	5.73e-05	0.00202	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	5.65e-05	0.00199	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—NR5A2—pancreatic cancer	5.41e-05	0.00191	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—SMAD4—pancreatic cancer	5.36e-05	0.00189	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PRSS1—pancreatic cancer	5.28e-05	0.00186	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—CTNNB1—pancreatic cancer	5.25e-05	0.00185	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—NOTCH3—pancreatic cancer	5.2e-05	0.00183	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—pancreatic cancer	5.05e-05	0.00178	CbGpPWpGaD
Prednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	4.99e-05	0.00176	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	4.92e-05	0.00174	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	4.83e-05	0.00171	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	4.71e-05	0.00166	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—STAT3—pancreatic cancer	4.58e-05	0.00161	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—ARG2—pancreatic cancer	4.57e-05	0.00161	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	4.55e-05	0.00161	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	4.54e-05	0.0016	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—MYC—pancreatic cancer	4.41e-05	0.00156	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	4.37e-05	0.00154	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	4.36e-05	0.00154	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	4.31e-05	0.00152	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	4.27e-05	0.00151	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—pancreatic cancer	4.26e-05	0.0015	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—TGFB1—pancreatic cancer	4.24e-05	0.0015	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	4.23e-05	0.00149	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	4.16e-05	0.00147	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—TYMP—pancreatic cancer	4e-05	0.00141	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	4e-05	0.00141	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—TNF—pancreatic cancer	3.96e-05	0.0014	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—NOTCH1—pancreatic cancer	3.95e-05	0.00139	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—SMAD4—pancreatic cancer	3.92e-05	0.00138	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PRSS1—pancreatic cancer	3.8e-05	0.00134	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—PPARG—pancreatic cancer	3.73e-05	0.00131	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	3.7e-05	0.0013	CbGpPWpGaD
Prednisolone—CYP2A6—NRF2 pathway—TGFB1—pancreatic cancer	3.49e-05	0.00123	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	3.42e-05	0.00121	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	3.4e-05	0.0012	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.3e-05	0.00116	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—ARG2—pancreatic cancer	3.29e-05	0.00116	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—GLP1R—pancreatic cancer	3.22e-05	0.00114	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—DPYD—pancreatic cancer	3.17e-05	0.00112	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—TNF—pancreatic cancer	3.17e-05	0.00112	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	3.15e-05	0.00111	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—MEN1—pancreatic cancer	3.11e-05	0.0011	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	3.02e-05	0.00106	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—SLC2A2—pancreatic cancer	3.01e-05	0.00106	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.98e-05	0.00105	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—NOTCH4—pancreatic cancer	2.94e-05	0.00104	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—NOTCH1—pancreatic cancer	2.89e-05	0.00102	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—TYMP—pancreatic cancer	2.88e-05	0.00101	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.87e-05	0.00101	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—HSPA1B—pancreatic cancer	2.81e-05	0.00099	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	2.75e-05	0.00097	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	2.73e-05	0.000961	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—PPARG—pancreatic cancer	2.72e-05	0.000961	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.62e-05	0.000923	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—EZH2—pancreatic cancer	2.56e-05	0.000902	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—NOTCH3—pancreatic cancer	2.5e-05	0.000883	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—HSPA1A—pancreatic cancer	2.37e-05	0.000836	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CD44—pancreatic cancer	2.33e-05	0.000822	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—GLP1R—pancreatic cancer	2.32e-05	0.000818	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	2.32e-05	0.000817	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.28e-05	0.000805	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—DPYD—pancreatic cancer	2.28e-05	0.000804	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.26e-05	0.000797	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PRSS1—pancreatic cancer	2.26e-05	0.000797	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—GCG—pancreatic cancer	2.23e-05	0.000788	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—SLC2A2—pancreatic cancer	2.16e-05	0.000763	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	2.15e-05	0.000759	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—MYC—pancreatic cancer	2.12e-05	0.000749	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—STK11—pancreatic cancer	2.1e-05	0.000741	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	2.09e-05	0.000739	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	2.07e-05	0.000731	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	2.02e-05	0.000713	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.97e-05	0.000695	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—ARG2—pancreatic cancer	1.96e-05	0.000691	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—SMAD4—pancreatic cancer	1.89e-05	0.000665	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.87e-05	0.000661	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.83e-05	0.000644	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—TYMS—pancreatic cancer	1.81e-05	0.000637	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—TYMP—pancreatic cancer	1.71e-05	0.000604	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.68e-05	0.000592	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CD44—pancreatic cancer	1.68e-05	0.000591	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.68e-05	0.000591	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.64e-05	0.000579	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—GCG—pancreatic cancer	1.61e-05	0.000567	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.56e-05	0.000552	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—MYC—pancreatic cancer	1.55e-05	0.000548	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.55e-05	0.000547	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—STK11—pancreatic cancer	1.51e-05	0.000533	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—AKT1—pancreatic cancer	1.47e-05	0.00052	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—APOE—pancreatic cancer	1.47e-05	0.000518	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.43e-05	0.000503	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.39e-05	0.000491	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.39e-05	0.000491	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—NOTCH1—pancreatic cancer	1.39e-05	0.00049	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.38e-05	0.000487	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.38e-05	0.000487	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—DPYD—pancreatic cancer	1.36e-05	0.000479	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PIK3CG—pancreatic cancer	1.33e-05	0.000468	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—PPARG—pancreatic cancer	1.31e-05	0.000463	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—TYMS—pancreatic cancer	1.3e-05	0.000458	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—SLC2A2—pancreatic cancer	1.29e-05	0.000454	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PPARG—pancreatic cancer	1.28e-05	0.000451	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.21e-05	0.000426	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PIK3CD—pancreatic cancer	1.17e-05	0.000411	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.16e-05	0.000411	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—APOE—pancreatic cancer	1.06e-05	0.000373	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.05e-05	0.000372	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PIK3CB—pancreatic cancer	1.02e-05	0.000358	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PTGS2—pancreatic cancer	1.01e-05	0.000355	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CD44—pancreatic cancer	9.98e-06	0.000352	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—GCG—pancreatic cancer	9.56e-06	0.000337	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PIK3CG—pancreatic cancer	9.54e-06	0.000336	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PPARG—pancreatic cancer	9.21e-06	0.000325	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—STK11—pancreatic cancer	8.99e-06	0.000317	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PTEN—pancreatic cancer	8.78e-06	0.00031	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—GLP1R—pancreatic cancer	8.5e-06	0.0003	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PIK3CD—pancreatic cancer	8.39e-06	0.000296	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—DPYD—pancreatic cancer	8.36e-06	0.000295	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	7.94e-06	0.00028	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—TYMS—pancreatic cancer	7.73e-06	0.000273	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—MYC—pancreatic cancer	7.48e-06	0.000264	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PIK3CB—pancreatic cancer	7.31e-06	0.000258	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PTGS2—pancreatic cancer	7.24e-06	0.000255	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PTEN—pancreatic cancer	6.32e-06	0.000223	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—APOE—pancreatic cancer	6.29e-06	0.000222	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PIK3CA—pancreatic cancer	6.19e-06	0.000218	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CD44—pancreatic cancer	6.15e-06	0.000217	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—GCG—pancreatic cancer	5.89e-06	0.000208	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PIK3CG—pancreatic cancer	5.68e-06	0.0002	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—STK11—pancreatic cancer	5.54e-06	0.000195	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PPARG—pancreatic cancer	5.48e-06	0.000193	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—AKT1—pancreatic cancer	5.19e-06	0.000183	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—AKT1—pancreatic cancer	5.06e-06	0.000178	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PIK3CD—pancreatic cancer	4.99e-06	0.000176	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—TYMS—pancreatic cancer	4.77e-06	0.000168	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PIK3CA—pancreatic cancer	4.46e-06	0.000157	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PIK3CB—pancreatic cancer	4.35e-06	0.000153	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PTGS2—pancreatic cancer	4.31e-06	0.000152	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—APOE—pancreatic cancer	3.88e-06	0.000137	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PTEN—pancreatic cancer	3.76e-06	0.000133	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—AKT1—pancreatic cancer	3.64e-06	0.000128	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	3.5e-06	0.000123	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PPARG—pancreatic cancer	3.38e-06	0.000119	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.07e-06	0.000108	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.68e-06	9.45e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.66e-06	9.37e-05	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PIK3CA—pancreatic cancer	2.65e-06	9.35e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.32e-06	8.17e-05	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—AKT1—pancreatic cancer	2.17e-06	7.64e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.63e-06	5.76e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.33e-06	4.71e-05	CbGpPWpGaD
